3-(7-Hydroxy-1-oxoisoindolin-2-yl)piperidine-2,6-dione

Catalog No. :
ACSHZP935
CAS No. :
1416990-10-7
Molecular Formula :
C13H12N2O4
Molecular Weight :
260.25

IUPAC Name:3-(7-hydroxy-1-oxoisoindolin-2-yl)piperidine-2,6-dione

3-(7-Hydroxy-1-oxoisoindolin-2-yl)piperidine-2,6-dione structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$59.00Login to see priceIn stockIn stock
1g97%$167.00Login to see priceIn stockIn stock
5g97%$757.00Login to see priceIn stockIn stock
25g97%$2786.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-(7-Hydroxy-1-oxoisoindolin-2-yl)piperidine-2,6-dione
IUPAC Name3-(7-hydroxy-1-oxoisoindolin-2-yl)piperidine-2,6-dione
MDL No.-
Molecular FormulaC13H12N2O4
Molecular Weight260.25
SMILESO=C(C(N(CC1=C2C(O)=CC=C1)C2=O)CC3)NC3=O
InChI KeyZHINEOZMGPJDNM-UHFFFAOYSA-N
Synonym2,6-Piperidinedione, 3-(1,3-dihydro-7-hydroxy-1-oxo-2H-isoindol-2-yl)-;3-(7-hydroxy-1-oxoisoindolin-2-yl)piperidine-2,6-dione;3-(7-hydroxy-1-oxo-2,3-dihydro-1H-isoindol-2-yl)piperidine-2,6-dione;3-(7-hydroxy-1-oxo-3H-isoindol-2-yl)piperidine-2,6-dione - [AC80378]
CAS No.1416990-10-7
PubChem CID71517904

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACSHZP935 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACSHZP935 route product structure diagram
    ACSHZP9351416990-10-7 In Stock
Inquiry

2. ACSHZP935 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACSHZP935 route product structure diagram
    ACSHZP9351416990-10-7 In Stock
Inquiry

Comments (0)